Question 1

How many shares of CTNM does UBS Group AG own?

Accepted Answer

As of 2026-Q2, UBS Group AG holds 130,642 shares of CTNM (CONTINEUM THERAPEUTICS INC).

Question 2

What is UBS Group AG's CTNM position worth?

Accepted Answer

As of 2026-Q2, UBS Group AG's CTNM position is worth $2.1M.

Question 3

Is UBS Group AG buying or selling CTNM?

Accepted Answer

In 2026-Q2, UBS Group AG decreased their CTNM position (-43.3% change in shares).

Question 4

When did UBS Group AG first buy CTNM?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in CTNM in 2024-Q2. They have held the position across 9 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	130,642	-43.3%	$2.1M	0.0%	$16.39	0
2026-Q1	Increased	230,409	+15.6%	$3M	0.0%	$14.10	30
2025-Q4	Increased	199,389	+191.1%	$2.3M	0.0%	$11.40	42
2025-Q3	Increased	68,504	+793.7%	$804,923	0.0%	$11.82	40
2025-Q2	Decreased	7,665	-42.3%	$30,430	0.0%	$4.11	0
2025-Q1	Decreased	13,294	-46.6%	$92,792	0.0%	$7.07	0
2024-Q4	Increased	24,881	+835.4%	$364,507	0.0%	$14.47	38
2024-Q3	Increased	2,660	+26.3%	$50,912	0.0%	$18.84	17
2024-Q2	New	2,107	-	$37,104	0.0%	$17.61	31

CTNM9 quarters

CTNM
9 quarters